Gift4

DuPont de Nemours, Inc.

Total Value

Filing Date

Aug 19, 2026

2 transactions

Trade Summary

On Aug 25, 2025 through Aug 17, 2026, BREEN EDWARD D, Director, reported $0 of DuPont de Nemours, Inc. (DD) across 2 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: BREEN EDWARD D
Role: Director
Location: WILMINGTON, DE

Filing Details

Filing Date: Aug 19, 2026
Transaction Date: Aug 25, 2025
Accession Number: 0001628280-26-058089
Form Type: 4

Non-Derivative Transactions

Date	Security	Shares	Price	Type	Value
Aug 25, 2025	Common Stock	53,000	—	Bona Fide Gift	—
Aug 17, 2026	Common Stock	34,485	—	Bona Fide Gift	—

Want live alerts when BREEN EDWARD D trades again?

Download Insider Trades to track DD, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)Represents annuity payments back to Mr. Breen from 2023 GRAT 12 and 2024 GRAT 9. The transactions are being reported late due to an inadvertent administrative error. The number of shares have been adjusted for the reverse stock split that occurred on June 1, 2026.
(F2)Represents the funding of new GRAT 2026-3.
(F3)Includes acquisition of shares pursuant to dividend reinvestment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BREEN EDWARD D

(Last)

(First)

(Middle)

CHESTNUT RUN PLAZA 730

974 CENTRE ROAD

(Street)

WILMINGTON

19805

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
DuPont de Nemours, Inc. [ DD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/25/2025		G	V	53,000⁽¹⁾	A	$0	125,977.9878	D
Common Stock	08/17/2026		G		34,485⁽²⁾	D	$0	91,492.9878⁽³⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents annuity payments back to Mr. Breen from 2023 GRAT 12 and 2024 GRAT 9. The transactions are being reported late due to an inadvertent administrative error. The number of shares have been adjusted for the reverse stock split that occurred on June 1, 2026.

2. Represents the funding of new GRAT 2026-3.

3. Includes acquisition of shares pursuant to dividend reinvestment.

Remarks:

	Paige Fleming by Power of Attorney	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001628280-26-058089.

DuPont de Nemours, Inc.

Trade Summary

Company Information

Insider Information

Filing Details

Non-Derivative Transactions

Want live alerts when BREEN EDWARD D trades again?

Footnotes

SEC Form 4

SEC Filing

SEC Form 4